Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease.

PubWeight™: 2.92‹?› | Rank: Top 1%

🔗 View Article (PMC 96770)

Published in Infect Immun on September 01, 1999

Authors

J Boudeau1, A L Glasser, E Masseret, B Joly, A Darfeuille-Michaud

Author Affiliations

1: Pathogénie Bactérienne Intestinale, Laboratoire de Bactériologie, Faculté de Pharmacie, 63001 Clermont-Ferrand, France.

Articles citing this

(truncated to the top 100)

Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01

A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet (2011) 3.59

Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science (2013) 3.54

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest (2007) 2.44

Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev (2013) 2.43

Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun (2001) 2.28

Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut (2006) 2.24

Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol (2009) 2.23

Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J Clin Invest (2011) 2.10

Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut (2014) 2.08

AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut (2013) 2.08

IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol (2012) 2.03

Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut (2015) 1.80

Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut (2010) 1.77

Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med (2009) 1.71

Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS One (2010) 1.69

Genetically related Escherichia coli strains associated with Crohn's disease. Gut (2001) 1.61

Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconj J (2003) 1.61

Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev (2005) 1.51

Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol (2013) 1.41

TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage. Mucosal Immunol (2010) 1.39

Identification of Candidate Adherent-Invasive E. coli Signature Transcripts by Genomic/Transcriptomic Analysis. PLoS One (2015) 1.38

Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun (2005) 1.33

The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol (2011) 1.27

Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun (2006) 1.26

Variations in the csgD promoter of Escherichia coli O157:H7 associated with increased virulence in mice and increased invasion of HEp-2 cells. Infect Immun (2002) 1.26

The role of infection in the aetiology of inflammatory bowel disease. J Gastroenterol (2010) 1.26

Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy (2011) 1.26

Immunopathogenesis of inflammatory bowel disease. Self Nonself (2011) 1.24

Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Appl Environ Microbiol (2005) 1.23

Strong decrease in invasive ability and outer membrane vesicle release in Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL gene deleted. J Bacteriol (2005) 1.23

Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics (2010) 1.21

Development of a unique small molecule modulator of CXCR4. PLoS One (2012) 1.18

The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis (2014) 1.13

Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains. J Clin Microbiol (2009) 1.12

The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut Liver (2010) 1.12

Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules. Infect Immun (2001) 1.09

Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes (2012) 1.08

Infection strategies of enteric pathogenic Escherichia coli. Gut Microbes (2012) 1.06

Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut (2010) 1.05

The metalloproteases meprin α and meprin β: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis. Biochem J (2013) 1.04

Involvement of lipoprotein NlpI in the virulence of adherent invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect Immun (2004) 1.02

Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr adhesins. Infect Immun (2003) 1.01

Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC). BMC Microbiol (2009) 1.01

Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol (2015) 1.00

Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli. Infect Immun (2005) 1.00

Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther (2013) 0.99

A Strong Impact of Genetic Background on Gut Microflora in Mice. Int J Inflam (2010) 0.99

Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol (2007) 0.97

Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients. PLoS One (2009) 0.97

The oxidoreductase DsbA plays a key role in the ability of the Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 to resist macrophage killing. J Bacteriol (2007) 0.97

Microbial imbalance and intestinal pathologies: connections and contributions. Dis Model Mech (2014) 0.96

Escherichia coli from Crohn's disease patient displays virulence features of enteroinvasive (EIEC), enterohemorragic (EHEC), and enteroaggregative (EAEC) pathotypes. Gut Pathog (2015) 0.95

HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect Immun (2005) 0.94

A role for the RNA chaperone Hfq in controlling adherent-invasive Escherichia coli colonization and virulence. PLoS One (2011) 0.94

Conversion of commensal Escherichia coli K-12 to an invasive form via expression of a mutant histone-like protein. MBio (2011) 0.94

NlpI contributes to Escherichia coli K1 strain RS218 interaction with human brain microvascular endothelial cells. Infect Immun (2010) 0.93

Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol (2014) 0.93

Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog (2013) 0.92

An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice. Infect Immun (2004) 0.92

Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis. PLoS One (2013) 0.92

Chitin-binding domains of Escherichia coli ChiA mediate interactions with intestinal epithelial cells in mice with colitis. Gastroenterology (2013) 0.91

Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia. BMC Microbiol (2009) 0.91

Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseases. PLoS One (2014) 0.91

Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease. Infect Immun (2012) 0.90

Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients. Gastroenterol Res Pract (2013) 0.90

Dysbiotic events in gut microbiota: impact on human health. Nutrients (2014) 0.87

Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol (2014) 0.87

Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines. Microbiol Mol Biol Rev (2013) 0.87

Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia. Infect Immun (2006) 0.86

Role of meprins to protect ileal mucosa of Crohn's disease patients from colonization by adherent-invasive E. coli. PLoS One (2011) 0.86

Activation of NF-kappaB in intestinal epithelial cells by E. coli strains isolated from the colonic mucosa of IBD patients. Int J Colorectal Dis (2004) 0.86

Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS One (2012) 0.86

Subversion of autophagy in adherent invasive Escherichia coli-infected neutrophils induces inflammation and cell death. PLoS One (2012) 0.86

Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features. BMC Res Notes (2014) 0.85

Complete genome sequence of the Crohn's disease-associated adherent-invasive Escherichia coli strain HM605. J Bacteriol (2011) 0.84

The IbeA invasin of adherent-invasive Escherichia coli mediates interaction with intestinal epithelia and macrophages. Infect Immun (2015) 0.84

Increased S-nitrosylation and proteasomal degradation of caspase-3 during infection contribute to the persistence of adherent invasive Escherichia coli (AIEC) in immune cells. PLoS One (2013) 0.84

Pathogenesis of Crohn's disease: Bug or no bug. World J Gastrointest Pathophysiol (2015) 0.84

The σE pathway is involved in biofilm formation by Crohn's disease-associated adherent-invasive Escherichia coli. J Bacteriol (2012) 0.83

Host defense peptide resistance contributes to colonization and maximal intestinal pathology by Crohn's disease-associated adherent-invasive Escherichia coli. Infect Immun (2014) 0.83

Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease. BMC Genomics (2011) 0.83

CEACAM6 gene variants in inflammatory bowel disease. PLoS One (2011) 0.83

Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation. Sci Rep (2016) 0.82

Cytotoxic Escherichia coli strains encoding colibactin colonize laboratory mice. Microbes Infect (2016) 0.82

Patterning bacterial communities on epithelial cells. PLoS One (2013) 0.82

New molecular insights into inflammatory bowel disease-induced diarrhea. Expert Rev Gastroenterol Hepatol (2011) 0.81

Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol (2014) 0.81

Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence. J Cyst Fibros (2009) 0.81

Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies. Biomed Res Int (2014) 0.81

Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease. World J Gastroenterol (2014) 0.81

Chitinase 3-like 1 synergistically activates IL6-mediated STAT3 phosphorylation in intestinal epithelial cells in murine models of infectious colitis. Inflamm Bowel Dis (2014) 0.81

Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection. Front Immunol (2015) 0.80

Human Microbiome: When a Friend Becomes an Enemy. Arch Immunol Ther Exp (Warsz) (2015) 0.80

Adherent-invasive Escherichia coli target the epithelial barrier. Gut Microbes (2010) 0.80

Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. ISME J (2015) 0.80

Representational difference analysis between Afa/Dr diffusely adhering Escherichia coli and nonpathogenic E. coli K-12. Infect Immun (2002) 0.80

Up-regulation of intestinal vascular endothelial growth factor by Afa/Dr diffusely adhering Escherichia coli. PLoS One (2007) 0.79

Analysis of Escherichia coli isolated from patients affected by Crohn's disease. Curr Microbiol (2011) 0.79

Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges. Clin Microbiol Rev (2014) 0.79

Articles cited by this

Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09

Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J Cell Biol (1989) 15.41

Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65

A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A (1990) 14.22

Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun (1982) 13.55

Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun (1983) 12.81

In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect Immun (1987) 11.24

Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev (1997) 10.52

Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36

Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell (1997) 9.60

Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect Immun (1986) 9.35

The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis (1985) 9.18

Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell (1990) 8.41

Cloning of plasmid DNA sequences involved in invasion of HeLa cells by Shigella flexneri. Infect Immun (1985) 6.74

Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci U S A (1995) 6.59

Exploitation of mammalian host cell functions by bacterial pathogens. Science (1997) 6.06

Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect Immun (1987) 5.92

E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell (1996) 5.82

The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid. Infect Immun (1991) 5.75

Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie (1988) 5.62

Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis (1988) 5.30

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02

Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet (1983) 4.89

Experimental bacillary dysentery. An electron microscopic study of the response of the intestinal mucosa to bacterial invasion. Am J Pathol (1965) 4.42

Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells. J Bacteriol (1989) 4.37

Ruffles induced by Salmonella and other stimuli direct macropinocytosis of bacteria. Nature (1993) 4.30

Cytoskeletal rearrangements accompanying salmonella entry into epithelial cells. J Cell Sci (1991) 4.18

Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. J Infect Dis (1990) 4.09

Surface presentation of Shigella flexneri invasion plasmid antigens requires the products of the spa locus. J Bacteriol (1992) 3.91

IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J (1992) 3.84

Comparison of the ability of enteroinvasive Escherichia coli, Salmonella typhimurium, Yersinia pseudotuberculosis, and Yersinia enterocolitica to enter and replicate within HEp-2 cells. Infect Immun (1987) 3.81

Intracellular replication is essential for the virulence of Salmonella typhimurium. Proc Natl Acad Sci U S A (1991) 3.47

Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor. J Infect Dis (1989) 3.34

Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii. Proc Natl Acad Sci U S A (1993) 3.29

Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J Bacteriol (1988) 3.24

Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals to epithelial cells. Proc Natl Acad Sci U S A (1995) 3.24

Localization of plasmid loci necessary for the entry of Shigella flexneri into HeLa cells, and characterization of one locus encoding four immunogenic polypeptides. J Gen Microbiol (1987) 3.05

A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli. FEMS Microbiol Lett (1990) 2.76

Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol (1997) 2.73

Characterization of interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells in vitro. J Infect Dis (1991) 2.53

The secreted Ipa complex of Shigella flexneri promotes entry into mammalian cells. Proc Natl Acad Sci U S A (1996) 2.37

Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut (1991) 2.24

An endocytic process in HEp-2 cells induced by enteropathogenic Escherichia coli. J Med Microbiol (1989) 2.13

Cytoskeletal rearrangements and the functional role of T-plastin during entry of Shigella flexneri into HeLa cells. J Cell Biol (1995) 2.06

Molecular characterization of the tia invasion locus from enterotoxigenic Escherichia coli. Infect Immun (1996) 1.87

Invasive potential of noncytotoxic enteropathogenic Escherichia coli in an in vitro Henle 407 cell model. Infect Immun (1989) 1.77

Escherichia coli antibodies in patients with inflammatory bowel disease. Gut (1978) 1.73

Identification of regions on a 230-kilobase plasmid from enteroinvasive Escherichia coli that are required for entry into HEp-2 cells. Infect Immun (1988) 1.69

Gonococcal opacity protein promotes bacterial entry-associated rearrangements of the epithelial cell actin cytoskeleton. Infect Immun (1996) 1.68

Adhesion to and invasion of HeLa cells by pathogenic Escherichia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively. Infect Immun (1997) 1.65

Invasion and the pathogenesis of Shigella infections. Curr Top Microbiol Immunol (1996) 1.60

Epithelial cell invasion and adherence directed by the enterotoxigenic Escherichia coli tib locus is associated with a 104-kilodalton outer membrane protein. Infect Immun (1994) 1.57

Molecular cloning of epithelial cell invasion determinants from enterotoxigenic Escherichia coli. Infect Immun (1992) 1.52

Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut (1986) 1.44

Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J Infect Dis (1997) 1.43

Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains. Infect Immun (1994) 1.34

In vivo translation of a region within the rrnB 16S rRNA gene of Escherichia coli. J Bacteriol (1987) 1.33

Actin accumulation associated with clustered and localized adherence in Escherichia coli isolated from patients with diarrhea. Infect Immun (1994) 1.27

Effect of cytochalasin B and dihydrocytochalasin B on invasiveness of entero-invasive bacteria in HEp-2 cell cultures. Acta Pathol Microbiol Immunol Scand B (1984) 1.25

MxiG, a membrane protein required for secretion of Shigella spp. Ipa invasins: involvement in entry into epithelial cells and in intercellular dissemination. Mol Microbiol (1995) 1.18

Characterization of HEp-2 cell projection formation induced by diffusely adherent Escherichia coli. Microb Pathog (1996) 1.10

Characterization of an invasive phenotype associated with enteroaggregative Escherichia coli. Infect Immun (1995) 1.04

An immunocytochemical search for infectious agents in Crohn's disease. Mod Pathol (1993) 1.02

Articles by these authors

Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother (1987) 6.27

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02

Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun (2001) 2.28

Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J Clin Microbiol (2000) 2.18

Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults. J Clin Microbiol (1998) 2.16

The DIM1 gene responsible for the conserved m6(2)Am6(2)A dimethylation in the 3'-terminal loop of 18 S rRNA is essential in yeast. J Mol Biol (1994) 2.01

Adhesion of enterotoxigenic Escherichia coli to the human colon carcinoma cell line Caco-2 in culture. Infect Immun (1990) 1.83

A new colonization factor antigen (CFA/III) produced by enteropathogenic Escherichia coli O128:B12. Ann Microbiol (Paris) (1983) 1.83

Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol (2001) 1.73

2'-O-methyl-5-formylcytidine (f5Cm), a new modified nucleotide at the 'wobble' of two cytoplasmic tRNAs Leu (NAA) from bovine liver. Nucleic Acids Res (1996) 1.71

R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections. Infect Immun (1992) 1.66

Consequences of reduction of Klebsiella pneumoniae capsule expression on interactions of this bacterium with epithelial cells. Infect Immun (1999) 1.65

Genetically related Escherichia coli strains associated with Crohn's disease. Gut (2001) 1.61

Escherichia coli strains involved in diarrhea in France: high prevalence and heterogeneity of diffusely adhering strains. J Clin Microbiol (1993) 1.57

Translocation of antibiotic resistance determinants including an extended-spectrum beta-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother (1991) 1.52

Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus. FEMS Microbiol Lett (1992) 1.52

Identification of a nonfimbrial adhesive factor of an enterotoxigenic Escherichia coli strain. Infect Immun (1986) 1.48

Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections. J Clin Microbiol (1996) 1.44

Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol (2001) 1.42

Molecular characterization and adhesive properties of CF29K, an adhesin of Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun (1995) 1.42

Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. Aliment Pharmacol Ther (2003) 1.40

Aggregative adherence of Klebsiella pneumoniae to human intestine-407 cells. Infect Immun (1995) 1.24

A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun (1996) 1.23

New adhesive factor (antigen 8786) on a human enterotoxigenic Escherichia coli O117:H4 strain isolated in Africa. Infect Immun (1991) 1.16

[Study of Enterobacter strains belonging to a particular group related to Enterobacter aerogenes (author's transl)]. Ann Microbiol (Paris) (1976) 1.09

A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid. J Antimicrob Chemother (1986) 1.04

Survey of clinical isolates of diarrhoeogenic Escherichia coli: diffusely adhering E. coli strains with multiple adhesive factors. Res Microbiol (1994) 1.02

Expression of receptors for enterotoxigenic Escherichia coli during enterocytic differentiation of human polarized intestinal epithelial cells in culture. Infect Immun (1992) 1.02

Scanning and transmission electron microscopic study of adherence of Escherichia coli O103 enteropathogenic and/or enterohemorrhagic strain GV in enteric infection in rabbits. Infect Immun (1991) 1.00

Sequence and molecular characterization of the ROB-1 beta-lactamase gene from Pasteurella haemolytica. Antimicrob Agents Chemother (1991) 0.98

Characterization of 20K fimbria, a new adhesin of septicemic and diarrhea-associated Escherichia coli strains, that belongs to a family of adhesins with N-acetyl-D-glucosamine recognition. Infect Immun (1996) 0.97

Enteroadherent Escherichia coli and diarrhea in children: a prospective case-control study. J Clin Microbiol (1996) 0.97

Relationship between adhesion to intestinal Caco-2 cells and multidrug resistance in Klebsiella pneumoniae clinical isolates. J Clin Microbiol (1997) 0.96

Identification and structural characterization of O-beta-ribosyl-(1"----2')-adenosine-5"-phosphate in yeast methionine initiator tRNA. Nucleic Acids Res (1990) 0.95

Characterization of a beta-lactamase from Pasteurella multocida. Ann Inst Pasteur Microbiol (1988) 0.94

Characterization of enteroaggregative Escherichia coli isolates. FEMS Microbiol Lett (1999) 0.94

Resistance to beta-lactams in Enterobacteriaceae: distribution of phenotypes related to beta-lactamase production. J Int Med Res (1986) 0.93

Identification of human enterovirulent Escherichia coli strains by multiplex PCR. J Clin Lab Anal (2001) 0.93

["In vitro" study of attachment to human enterocytes in "Escherichia coli" strains isolated from infants with diarrheal disease (author's transl)]. Ann Microbiol (Paris) (1982) 0.92

CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease. Int J Immunogenet (2007) 0.92

Children's bicycle helmet use and injuries in Hillsborough County, Florida before and after helmet legislation. Inj Prev (2003) 0.90

The primary structure of cytoplasmic initiator tRNA(Met) from Schizosaccharomyces pombe. Nucleic Acids Res (1993) 0.88

Retracted R plasmid in Escherichia coli O103 coding for colonization of the rabbit intestinal tract. Infect Immun (1991) 0.87

[In vitro bactericidal activity of trimethoprim combined with different antibiotics]. Pathol Biol (Paris) (1972) 0.87

Self-transmissible R plasmids encoding CS31A among human Escherichia coli strains isolated from diarrheal stools. Infect Immun (1994) 0.87

Adhesive properties of enteropathogenic Escherichia coli isolated from infants with acute diarrhea in Africa. Eur J Clin Microbiol Infect Dis (1989) 0.86

[The resistance of "Pseudomonas" to antibiotics and heavy metal: minimal inhibitory concentrations and genetic transfers (author's transl)]. Ann Microbiol (Paris) (1976) 0.86

Nucleotide sequence of the nfaA gene encoding the antigen 8786 adhesive factor of enterotoxigenic Escherichia coli. FEMS Microbiol Lett (1992) 0.86

Exposure in utero to maternal diabetes leads to glucose intolerance and high blood pressure with no major effects on lipid metabolism. Diabetes Metab (2011) 0.86

The central variable V2 region of the CS31A major subunit is involved in the receptor-binding domain. Infect Immun (1997) 0.84

E. coli-mediated gut inflammation in genetically predisposed Crohn's disease patients. Pathol Biol (Paris) (2010) 0.84

Infectious agents and Crohn's disease. Clin Microbiol Infect (1999) 0.82

[Caustic burns. Clinical study of 24 patients with sulfuric acid burns in Cambodia]. Ann Chir Plast Esthet (2004) 0.82

[Proposal for a method of studying the activity of soap or antiseptic against the microbial flora of the hands after a single surgical scrub]. Pathol Biol (Paris) (1986) 0.81

Epidemiological study of pap genes among diarrheagenic or septicemic Escherichia coli strains producing CS31A and F17 adhesins and characterization of Pap(31A) fimbriae. J Clin Microbiol (2000) 0.81

[A new mechanism of resistance to ampicillin by production of beta-lactamase ROB-1 in a strain of Haemophilus influenzae isolated in France]. Presse Med (1987) 0.80

[Multicenter study of the antimicrobial activity of antiseptics on the hands. Protocols and results]. Pathol Biol (Paris) (1984) 0.80

Long-term maintenance of drug-metabolizing enzyme activities in rat hepatocytes after cryopreservation. Toxicol Appl Pharmacol (1997) 0.79

[Factors intervening in the variations of in vitro adhesion power of enterotoxinogenic colibacillus (ETEC) to human enterocytes]. Pathol Biol (Paris) (1991) 0.79

Loss of heterozygosity at the TP53 gene: independent occurrence from genetic instability events in node-negative breast cancer. Int J Cancer (1997) 0.79

[Qualitative and quantitative analysis of the residual hand flora after hygienic-type washing with a soap and a foaming antiseptic solution]. Pathol Biol (Paris) (1984) 0.78

Local appendiceal dysbiosis: the missing link between the appendix and ulcerative colitis? Gut (2011) 0.78

Multiplicity of serogroups and adhesins in enteropathogenic and enterotoxigenic Escherichia coli isolated from acute diarrhea in Senegal. J Clin Microbiol (1987) 0.78

[Efficacy of an ultraviolet device for the disinfection of radiology cassettes]. Pathol Biol (Paris) (1998) 0.78

Effects of antibiotics on adhesion of enterotoxigenic Escherichia coli strains. Eur J Clin Microbiol (1984) 0.78

Adhesive properties of Haemophilus influenzae to different human cells. Pathol Biol (Paris) (1991) 0.77

Advantages and limitations of the use of isolated kidney tubules in pharmacotoxicology. Cell Biol Toxicol (1996) 0.77

Characteristics and diffusion in the rabbit of a phage for Escherichia coli 0103. Attempts to use this phage for therapy. Vet Microbiol (1992) 0.77

Isolation and molecular characterization of an ROB-1 beta-lactamase plasmid in a Haemophilus influenzae strain in France. Eur J Clin Microbiol Infect Dis (1988) 0.77

Characterization of Haemophilus influenzae isolated from patients with otitis media. Eur J Clin Microbiol Infect Dis (1988) 0.77

Inhibitory effect of roxithromycin on adhesion of Klebsiella pneumoniae strains 3051, CF504 and LM21. J Antimicrob Chemother (1998) 0.77

Oral administration of a glutamine-enriched diet before or after endotoxin challenge in aged rats has limited effects. J Nutr (1999) 0.77

Modified nucleotides in Bacillus subtilis tRNA(Trp) hyperexpressed in Escherichia coli. Nucleic Acids Res (1993) 0.77

Spread of SHV-1 beta-lactamase in Escherichia coli isolated from fecal samples in Africa. Antimicrob Agents Chemother (1987) 0.75

[Severe Bordetella pertussis pneumonia in an immunocompetent adult]. Med Mal Infect (2011) 0.75

[Study of the mercury resistance in hospital enterobacteria: genetic and epidemiologic aspects (author's transl)]. Ann Microbiol (Paris) (1978) 0.75

[Study of the bismuth effect on bacteria, specially on faecal flora (author's transl)]. Ann Pharm Fr (1980) 0.75

[Galactosemias]. Rein Foie (1966) 0.75

[Activity of antibiotics and heavy metals against "Aeromonas" isolated from aquatic environments: phenotypic and genetic transfers (author's transl)]. Ann Microbiol (Paris) (1979) 0.75

[Assessment of surgical operations for obliterative arterial disease of the lower limbs by irrigraphy (author's transl)]. Chirurgie (1980) 0.75

[Bactericidal activity "in vitro" of sulfamethoxazol-tri-methoprime (SMZ-TMP) alone and in combination with various antibiotics on bacterial strains isolated from urinary tract infections (author's transl)]. Pathol Biol (Paris) (1979) 0.75